Comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 vs 3m Syndrome 3 C3280146
Clinical comparison between 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome and 3M Syndrome 3 for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
A severe mitochondrial disorder affecting the brain, hearing, and energy metabolism. It causes progressive neurological decline, hearing loss, and metabolic problems. Management requires intensive supportive care.
3m Syndrome 3 C3280146
A genetic condition causing intrauterine growth restriction and postnatal short stature with distinctive facial features. Treatment focuses on growth monitoring and supportive measures.
6 comparison axes
Onset
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
0-5
3m Syndrome 3 C3280146
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
severe
3m Syndrome 3 C3280146
moderate
Different severity levels
Chronic
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
Chronic
3m Syndrome 3 C3280146
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
No
3m Syndrome 3 C3280146
No
Different transmission
Body System
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3m Syndrome 3 C3280146
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
metabolic
3m Syndrome 3 C3280146
genetic
Different category
Bottom line
3-methylglutaconic-aciduria-with-deafness-encephalopathy-and-leigh-like-syndrome-C4040739 and 3m-syndrome-3-C3280146 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3m Syndrome 3 C3280146 | Discriminating power |
|---|---|---|---|
| Neurologic course | Progressive encephalopathy and Leigh-like brain involvement are described. | Primary encephalopathy is not described. | High |
| Hearing | Hearing loss is a named feature. | Hearing loss is not established by the source. | High |
| Growth pattern | Growth restriction is not the defining feature in the source. | Intrauterine growth restriction and postnatal short stature are central. | High |
When to favor each condition
Choose 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 when
Early progressive neurologic decline with hearing loss
This aligns with the described severe brain, hearing, and metabolic phenotype.
Moderate
Suspected disorder of energy metabolism
The source classifies the left condition as severe and metabolic.
Moderate
Need for intensive neurologic supportive care
Management is described as intensive supportive care rather than growth-focused care.
Moderate
Choose 3m Syndrome 3 C3280146 when
Prenatal growth restriction with persistent short stature
These are the principal features supplied for 3M syndrome 3.
Moderate
Distinctive facial features without metabolic encephalopathy
The source emphasizes a genetic musculoskeletal growth phenotype.
Moderate
Planning growth monitoring and supportive measures
Described management centers on monitoring and support, not intensive metabolic care.
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739 | 3m Syndrome 3 C3280146 | Interpretation |
|---|---|---|---|
| Urine organic-acid analysis | May suggest 3-methylglutaconic aciduria; no cutoff is supplied. | No characteristic organic-acid abnormality is described. | An abnormal result supports evaluation but does not alone establish the diagnosis. |
| Neuroimaging and hearing assessment | Leigh-like changes and hearing impairment may be investigated. | These are not described as primary diagnostic findings. | Results need correlation with age, course, and specialist assessment. |
| Growth and genetic evaluation | Metabolic genetics may be considered; exact testing is not specified. | Growth assessment and syndrome-directed genetic evaluation are central. | Genetic or growth findings require clinician confirmation and counseling. |
Prognosis comparison
3 Methylglutaconic Aciduria With Deafness Encephalopathy And Leigh Like Syndrome C4040739
- Outcome
- Potentially severe and progressive; survival data are not established here.
- Factors
- Neurologic course, metabolic stability, hearing loss, and supportive-care needs.
3m Syndrome 3 C3280146
- Outcome
- Generally a chronic moderate growth disorder; mortality is not established here.
- Factors
- Degree of short stature, associated features, and access to supportive care.
Time frame: From prenatal life or early childhood into long-term follow-up; course varies.
Confirmation, complications, development, nutrition, and specialist follow-up influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurologic deterioration | Progressive neurological decline is described. Not described as a primary complication. Exact progression and outcomes are not established by the source. |
| Hearing impairment | Hearing loss may require audiologic follow-up. Hearing involvement is not established here. Management details and severity thresholds are not supplied. |
| Short stature | Not identified as the defining complication. Postnatal short stature is a core feature. Functional impact varies; no treatment dose is established here. |
Patient education highlights
- HighSpecialist interpretation
Both are rare conditions. A label should be confirmed and explained by an appropriate specialist.
- HighUrgent changes
Seek urgent care for reduced alertness, seizures, breathing difficulty, or poor feeding.
- MediumTests versus diagnosis
An abnormal laboratory or imaging result is not automatically a diagnosis.